Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Thibaut Belmondo
Observed names:
Belmondo, Thibaut,
T. Belmondo
Institutions:
Université Paris-Est Créteil,
Centre Hospitalier Universitaire Henri-Mondor,
Assistance Publique – Hôpitaux de Paris,
Hôpitaux Universitaires Henri-Mondor
Observed institutions:
Inserm,
Université Paris-Est Créteil,
Centre Hospitalier Universitaire Henri-Mondor,
Assistance Publique – Hôpitaux de Paris,
Hôpitaux Universitaires Henri-Mondor,
Hôpital Albert-Chenevier,
Laboratoire d'hématologie
show all 7
ORCID:
0009-0007-1220-726X
Observed ORCID:
0009-0007-1220-726X
OpenAlex ID:
A5012725632
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study
2016
·
Lucile Musset
, Yves Allenbach
, et al.
·
Autoimmunity Reviews
·
134
Solid phase assays versus automated indirect immunofluorescence for detection of antinuclear antibodies
2018
·
Jolien Claessens
, Thibaut Belmondo
, et al.
·
Autoimmunity Reviews
·
74
PDF
Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients
2023
·
Réda Chebani
, Florian Lombart
, et al.
·
British Journal of Dermatology
·
55
PDF
Auto-antibodies against type I IFNs in > 10% of critically ill COVID-19 patients: a prospective multicentre study
2022
·
Romain Arrestier
, Paul Bastard
, et al.
·
Annals of Intensive Care
·
41
PDF
Identification of factors impairing exercise capacity after severe COVID-19 pulmonary infection: a 3-month follow-up of prospective COVulnerability cohort
2022
·
Bruno Ribeiro Baptista
, Thomas d’Humières
, et al.
·
Respiratory Research
·
38
PDF
Harmonization of clinical interpretation of antinuclear antibody test results by solid phase assay and by indirect immunofluorescence through likelihood ratios
2019
·
Xavier Bossuyt
, Jolien Claessens
, et al.
·
Autoimmunity Reviews
·
32
Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study
2023
·
Stephanie Guillet
, Etienne Crickx
, et al.
·
Blood
·
31
Antinuclear antibodies by indirect immunofluorescence and solid phase assays
2019
·
Xavier Bossuyt
, Jolien Claessens
, et al.
·
Annals of the Rheumatic Diseases
·
29
PDF
Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients
2022
·
Nicolas Chapuis
, Nusaibah Ibrahimi
, et al.
·
EBioMedicine
·
28
PDF
Positive Direct Immunofluorescence Is of Better Value than ELISA-BP180 and ELISA-BP230 Values for the Prediction of Relapse after Treatment Cessation in Bullous Pemphigoid: A Retrospective Study of 97 Patients
2015
·
Saskia Ingen-Housz-Oro
, Julie Plée
, et al.
·
Dermatology
·
20
Anti‐BP180 IgG antibody ELISA values correlate with adverse pregnancy outcomes in pemphigoid gestationis
2023
·
Nadège Cordel
, Jasmine Flament
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
16
PDF
High Levels of Anti-GM-CSF Antibodies in Deep Infiltrating Endometriosis
2020
·
Laurie Toullec
, Frédéric Batteux
, et al.
·
Reproductive Sciences
·
13
Bullous pemphigoid: Three main clusters defining 3 outcome profiles
2022
·
Florine Guerrois
, Elsa Hassan
, et al.
·
Journal of the American Academy of Dermatology
·
7
Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study
2025
·
Olivier Tournilhac
, Kamal Bouabdallah
, et al.
·
Blood Advances
·
5
PDF
Functional decline among bullous pemphigoid patients: A retrospective monocentric cohort study
2024
·
R. Ouakrat
, B. Peiffer
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
4
Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Final Analysis of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"
2022
·
Olivier Tournilhac
, Solene Lecolant
, et al.
·
Blood
·
4
Affinity-matured B cell responses neutralizing type-I interferons underlie severe viral infections
2026
·
Morgane Fournier
, Matthias Vanderkerken
, et al.
·
Cell
·
3
Maintenance treatment of pemphigus with rituximab in real life: A single-center study of 50 patients
2024
·
A. Louchez
, T. El Aarbaoui
, et al.
·
Annales de Dermatologie et de Vénéréologie
·
3
Real-life impact of immunologic tests to predict relapse after treatment cessation in patients with bullous pemphigoid: A French multicenter retrospective study
2022
·
Gilles Battesti
, Charline Garcia
, et al.
·
Journal of the American Academy of Dermatology
·
3
Anti-Ki/anti-PA28γ autoantibodies contribute to the HEp-2 indirect immunofluorescence nuclear speckled pattern
2022
·
Lise Boon
, Thibaut Belmondo
, et al.
·
Clinical Chemistry and Laboratory Medicine (CCLM)
·
2
Case Report: Pediatric immune-mediated necrotizing myopathies mimicking inherited muscle disorders: clinical, paraclinical, and genetic insights from two cases
2026
·
Gianmarco Severa
, Maria Camila Cortes-Rojas
, et al.
·
Frontiers in Pediatrics
PDF
Des anticorps neutralisants préexistants ciblant des épitopes structurellement divers de l’interféron de type I sont à l’origine de formes sévères de COVID-19
2025
·
M. Fournier
, M. Vanderkerken
, et al.
·
La Revue de Médecine Interne
Combined intercellular and basement membrane zone deposits in pemphigus: Frequency and implications
2025
·
Jeanne Emile
, Sabine Grootenboer‐Mignot
, et al.
·
Journal of the European Academy of Dermatology and Venereology
Lupus-Lyell : une cause rare de nécrolyse épidermique
2024
·
R. Ouakrat
, D. Thomas-Beaulieu
, et al.
·
Annales de Dermatologie et de Vénéréologie - FMC
Les autoanticorps des maladies bulleuses auto-immunes
2021
·
F. Morin
, T. Belmondo
, et al.
·
Annales de Dermatologie et de Vénéréologie - FMC
Show more works
View as search
Works count:
36
Citation count:
540
H-index:
12
I10-index:
12
Year
Topic
Type